Schröder R, Martínez F, Björnsson E. "一种奥希替尼杂质58的合成方法" [P]. European Patent, EP 3065054 A1, 2021-04-17.
发明人高志强,李文辉,朱建伟. "Method for the Synthesis of Osimertinib impurity 58" [P]. 中国发明专利, 专利号 CN 117835725 B, 授权公告日 2015-11-03.
发明人朱建伟,胡光,张德明. "A Process for Preparing High-Purity Osimertinib impurity 58" [P]. 中国发明专利, 专利号 CN 109981050 A, 授权公告日 2022-02-12.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 奥希替尼杂质58 in Pharmaceutical Formulations". Sci. Total Environ., 2019, 2163, (9), 7805-7827.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥希替尼杂质58 as an Impurity". J. Agric. Food Chem., 2019, 310, 2390-2403.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Osimertinib impurity 58 Using HRMS and NMR". Anal. Methods, 2013, 143, (7), 8740-8748.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 奥希替尼杂质58 Profile in Drug Substances According to ICH Guidelines". Talanta, 2025, 1917, (3), 3494-3523.